Background: The role of tumour-infiltrating inflammation in the prognosis of patients with
colorectal cancer (CRC) has not been fully evaluated. The primary objective of our meta …

A substantial number of clinical trials using antiangiogenic therapies are ongoing worldwide.
How to achieve the maximum benefit from these therapies and how to monitor patient …

We performed a meta-analysis of all published studies relating intratumoural microvessel
density (MVD)(45 studies) or vascular endothelial growth factor (VEGF) expression (27 …

Colorectal cancer progression and survival is dependent on complex interactions between
the tumour and the host. The pronounced local inflammatory response in and around the …

Purpose In colorectal cancer (CRC), whether the immune score can be used to predict the
clinical prognosis of the patient has not been completely established. Besides, the …

Colorectal tumors have been classified based on histologic factors, genetic factors, and
consensus molecular subtypes, all of which affect the tumor microenvironment. Elements of …

Introduction The host anti-tumour inflammatory response is a strong prognostic indicator,
and tumour infiltrating lymphocytes (TILs) are believed to have a complimentary role …

Angiogenesis is a key factor in the growth and dissemination of colorectal cancer, with
significant implications for its clinical management. Previous trials have provided proof-of …

Objective To review the current data on the prognostic and therapeutic implications of tumor
angiogenesis in gastrointestinal cancers. Summary Background Data Numerous studies …

Objective: The aim of this study was to examine the relationship between tissue factor (TF),
vascular endothelial growth factor (VEGF) and the onset of angiogenesis in the adenoma …